Progestin Market Growth Report and Size by 2031
The Progestin Market is expected to register a CAGR of 13.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX million by 2031.
The report is segmented by Progestin Market By Type (Progestin Oral, Progestin Injection, Progestin Suspended/Gel); Application (Hospital, Clinic, Pharmacies and Drug Stores), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Progestin Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Progestin Market Segmentation
By Type- Progestin Oral
- Progestin Injection
- Progestin Suspended/Gel
- Hospital
- Clinic
- Pharmacies and Drug Stores
Strategic Insights
Progestin Market Growth Drivers- Rising Prevalence of Hormonal Disorders: The need for progestin treatments is being driven mostly by the rising incidence of hormonal conditions like amenorrhea, polycystic ovarian syndrome (PCOS), and irregular uterine bleeding. In order to properly control symptoms, these illnesses frequently call for hormone therapy, which fuels market expansion.
- Growing Awareness and Acceptance of Hormonal Therapies: Patients and medical professionals are becoming more conscious of the advantages of hormonal treatments, such as progestin. More people are accepting and using these therapies as a result of educational programs and more discussion about women's health issues.Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
- Advanced Solutions: Its use in contraceptive techniques supports the progestin market. Because they are less likely to cause negative effects than combined hormonal contraceptives, progestin-only contraceptives, sometimes known as mini-pills, are becoming more and more popular. For women who are unable to take estrogen, this development is especially pertinent, which increases demand for progestin-based alternatives.
- Technological Advancements: Patient satisfaction and compliance are being improved by advancements in drug delivery methods and formulations, such as the creation of safer and more effective progestin treatments. Patients now have more alternatives thanks to new formulations including intrauterine devices (IUDs) and long-acting injectables.
- Aging Population: Progestin and other hormone replacement treatments are in greater demand as the number of menopausal women rises. The market for progestin products is anticipated to grow as women look for effective ways to control menopausal symptoms.More patients are turning to hormone therapy as part of their management strategies as a result of the increase in uterine and breast cancer diagnoses. To lessen the symptoms of these disorders, progestin medication is frequently combined with other therapies.
- Investment in Women's Health Initiatives: Governments and healthcare institutions are investing more in women's health, which encourages the development of progestin and other hormone medicines. This emphasis on enhancing the health of women encourages market growth.Market expansion is aided by favorable regulatory frameworks and the health authorities' approval of novel progestin formulations. Patients now have more access to efficient therapy alternatives thanks to recent product approvals and launches.
- Innovative Drug Delivery Systems: Progestin drugs are becoming more convenient and effective thanks to developments in drug delivery methods such transdermal patches, vaginal rings, and sustained-release formulations. Compared to conventional oral tablets, these systems reduce the frequency of delivery, improving patient compliance and enabling more stable hormone levels in the bloodstream.
- Long-Acting Injectable Formulations: Long-acting injectable progestins are becoming more and more popular as a dependable way of birth control. For women who might forget to take oral contraceptives on a regular basis, these formulations offer prolonged protection against pregnancy and do away with the necessity for daily dosing.
- Personalized Medicine Approaches: Hormonal therapies that use personalized medicine provide customized treatment regimens based on the unique characteristics of each patient. This method leads to safer and more successful progestin treatments by taking into account variables including lifestyle, hormone levels, and genetic susceptibility.Natural progesterone formulations made from plant sources like yams and soybeans are the subject of continuing study. These natural substitutes are becoming more and more well-liked because of their good safety records and successful patient outcomes, which can improve treatment regimen adherence.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Progestin Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Progestin Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
High Competition and Price Pressure
Europe region is expected to witness a high growth rate in terms of CAGR after Asia Pacific region during the forecast period
Asia Pacific region is expected to witness the highest growth during the forecast period
Rising Prevalence of Hormonal Disorders
The Progestin Market is estimated to witness a CAGR of 13.5% from 2023 to 2031
Innovative Drug Delivery Systems
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Progestin Market - By Type
1.3.2 Progestin Market - By Application
1.3.3 Progestin Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PROGESTIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PROGESTIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PROGESTIN MARKET - GLOBAL MARKET ANALYSIS
6.1. PROGESTIN - GLOBAL MARKET OVERVIEW
6.2. PROGESTIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. PROGESTIN MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PROGESTIN ORAL
7.3.1. Overview
7.3.2. Progestin Oral Market Forecast and Analysis
7.4. PROGESTIN INJECTION
7.4.1. Overview
7.4.2. Progestin Injection Market Forecast and Analysis
7.5. PROGESTIN SUSPENDED/GEL
7.5.1. Overview
7.5.2. Progestin Suspended/Gel Market Forecast and Analysis
8. PROGESTIN MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. PHARMACIES AND DRUG STORES
8.5.1. Overview
8.5.2. Pharmacies and Drug Stores Market Forecast and Analysis
9. PROGESTIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Progestin Market Overview
9.1.2 North America Progestin Market Forecasts and Analysis
9.1.3 North America Progestin Market Forecasts and Analysis - By Type
9.1.4 North America Progestin Market Forecasts and Analysis - By Application
9.1.5 North America Progestin Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Progestin Market
9.1.5.1.1 Canada Progestin Market by Type
9.1.5.1.2 Canada Progestin Market by Application
9.1.5.2 Mexico Progestin Market
9.1.5.2.1 Mexico Progestin Market by Type
9.1.5.2.2 Mexico Progestin Market by Application
9.1.5.3 US Progestin Market
9.1.5.3.1 US Progestin Market by Type
9.1.5.3.2 US Progestin Market by Application
9.2. EUROPE
9.2.1 Europe Progestin Market Overview
9.2.2 Europe Progestin Market Forecasts and Analysis
9.2.3 Europe Progestin Market Forecasts and Analysis - By Type
9.2.4 Europe Progestin Market Forecasts and Analysis - By Application
9.2.5 Europe Progestin Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Progestin Market
9.2.5.1.1 Germany Progestin Market by Type
9.2.5.1.2 Germany Progestin Market by Application
9.2.5.2 France Progestin Market
9.2.5.2.1 France Progestin Market by Type
9.2.5.2.2 France Progestin Market by Application
9.2.5.3 Italy Progestin Market
9.2.5.3.1 Italy Progestin Market by Type
9.2.5.3.2 Italy Progestin Market by Application
9.2.5.4 Spain Progestin Market
9.2.5.4.1 Spain Progestin Market by Type
9.2.5.4.2 Spain Progestin Market by Application
9.2.5.5 United Kingdom Progestin Market
9.2.5.5.1 United Kingdom Progestin Market by Type
9.2.5.5.2 United Kingdom Progestin Market by Application
9.2.5.6 Rest of Europe Progestin Market
9.2.5.6.1 Rest of Europe Progestin Market by Type
9.2.5.6.2 Rest of Europe Progestin Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Progestin Market Overview
9.3.2 Asia-Pacific Progestin Market Forecasts and Analysis
9.3.3 Asia-Pacific Progestin Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Progestin Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Progestin Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Progestin Market
9.3.5.1.1 Australia Progestin Market by Type
9.3.5.1.2 Australia Progestin Market by Application
9.3.5.2 China Progestin Market
9.3.5.2.1 China Progestin Market by Type
9.3.5.2.2 China Progestin Market by Application
9.3.5.3 India Progestin Market
9.3.5.3.1 India Progestin Market by Type
9.3.5.3.2 India Progestin Market by Application
9.3.5.4 Japan Progestin Market
9.3.5.4.1 Japan Progestin Market by Type
9.3.5.4.2 Japan Progestin Market by Application
9.3.5.5 South Korea Progestin Market
9.3.5.5.1 South Korea Progestin Market by Type
9.3.5.5.2 South Korea Progestin Market by Application
9.3.5.6 Rest of Asia-Pacific Progestin Market
9.3.5.6.1 Rest of Asia-Pacific Progestin Market by Type
9.3.5.6.2 Rest of Asia-Pacific Progestin Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Progestin Market Overview
9.4.2 Middle East and Africa Progestin Market Forecasts and Analysis
9.4.3 Middle East and Africa Progestin Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Progestin Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Progestin Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Progestin Market
9.4.5.1.1 South Africa Progestin Market by Type
9.4.5.1.2 South Africa Progestin Market by Application
9.4.5.2 Saudi Arabia Progestin Market
9.4.5.2.1 Saudi Arabia Progestin Market by Type
9.4.5.2.2 Saudi Arabia Progestin Market by Application
9.4.5.3 U.A.E Progestin Market
9.4.5.3.1 U.A.E Progestin Market by Type
9.4.5.3.2 U.A.E Progestin Market by Application
9.4.5.4 Rest of Middle East and Africa Progestin Market
9.4.5.4.1 Rest of Middle East and Africa Progestin Market by Type
9.4.5.4.2 Rest of Middle East and Africa Progestin Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Progestin Market Overview
9.5.2 South and Central America Progestin Market Forecasts and Analysis
9.5.3 South and Central America Progestin Market Forecasts and Analysis - By Type
9.5.4 South and Central America Progestin Market Forecasts and Analysis - By Application
9.5.5 South and Central America Progestin Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Progestin Market
9.5.5.1.1 Brazil Progestin Market by Type
9.5.5.1.2 Brazil Progestin Market by Application
9.5.5.2 Argentina Progestin Market
9.5.5.2.1 Argentina Progestin Market by Type
9.5.5.2.2 Argentina Progestin Market by Application
9.5.5.3 Rest of South and Central America Progestin Market
9.5.5.3.1 Rest of South and Central America Progestin Market by Type
9.5.5.3.2 Rest of South and Central America Progestin Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PROGESTIN MARKET, KEY COMPANY PROFILES
11.1. MERCK
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ZHEJIANG XIANJU PHARMACEUTICAL
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BESINS HEALTHCARE
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. VIRTUS PHARMACEUTICALS, LLC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BIONPHARMA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ALLERGAN
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TEVA PHARMACEUTICALS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BAYER AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. GLAXOSMITHKLINE
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Merck
2. Zhejiang Xianju Pharmaceutical
3. Besins Healthcare
4. Virtus Pharmaceuticals, LLC
5. BionPharma
6. Allergan
7. Pfizer Inc.
8. Teva Pharmaceuticals
9. Bayer AG
10. GlaxoSmithKline
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For